FDA OKs Abraxane for Pancreatic Cancer

WASHINGTON (MedPage Today) -- The FDA has expanded the indications for protein-bound paclitaxel (Abraxane) to include treatment of late-stage pancreatic cancer.
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news